Skip to content

Author

Santhosh L. Gaonkar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Safety-guided selection of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: toxicity profiles, dose modification, and clinical risk–benefit considerations

CDK4/6i selection should therefore be individualized according to toxicity profile, comorbidities, monitoring feasibility, and patient preference, with cautious interpretation of indirect comparative and real-world evidence.

Nidhi Shrivastava, Santhosh L. Gaonkar, Fayaz Shaik Mahammad · 0 citations
Review Open access Jul 2026

Unravelling recent advances in 1,2,4-triazole-based anticancer agents: synthetic strategies, molecular targets, molecular docking studies, and structure–activity relationships

Recent advances in 1,2,4-triazole chemistry and its biological role in the development of anticancer targets through the inhibition of EGFR, VEGFR-2 and different carbonic anhydrase enzymes are presented.

Glanish Jude Martis, Eshitha Jane D. Souza, Praveen S. Mugali et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.